Home  >  Products  >  HEMGN (hemogen) Blocking Peptide (the N terminal of HEMGN)(100ug)
HEMGN (hemogen) Blocking Peptide (the N terminal of HEMGN)(100ug)

HEMGN (hemogen) Blocking Peptide (the N terminal of HEMGN)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-HEMGN Antibody(ARP57794_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57794
Size: 100ug
Weight: 55kDa
Gene: 55363
Format: Lyophilized powder
Target: HEMGN regulates the proliferation and differentiation of hematopoietic cells. Overexpression of HEMGN block the TPA-induced megakaryocytic differentiation in the K562 cell model. HEMGN may also prevent cell apoptosis through the activation of the nuclear factor-kappa B (NF-kB).
Alternative names: EDAG; EDAG-1